Home › Funds › Marshall Wace › NMRA
Marshall Wace position in NMRA
NEUMORA THERAPEUTICS INC. · Health Care
Latest position (Q2 2026)904.46K sh
Reported value held$1.54M
Portfolio Weight0.00%
First reportedQ3 2023
Last changeReduce
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 256.41K | $3.62M | New |
| Q2 2024 | 134.54K | $1.32M | New |
| Q2 2025 | 250.49K | $182.86K | New |
| Q4 2025 | 583.76K | $1.04M | New |
| Q1 2026 | 1.20M | $2.33M | Add |
| Q2 2026 | 904.46K | $1.54M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding NMRA
- BlackRock Inc 7.79M sh · $13.25M · Q2 2026
- Vanguard Group 4.54M sh · $8.13M · Q4 2025
- Fidelity Management & Research (FMR) 3.50M sh · $5.95M · Q2 2026
- Geode Capital Management 2.61M sh · $4.43M · Q2 2026
- Two Sigma Investments 2.24M sh · $3.82M · Q2 2026
- Renaissance Technologies 1.26M sh · $2.15M · Q2 2026
- Citadel Advisors 1.07M sh · $1.82M · Q2 2026
- Charles Schwab Investment Management 823.58K sh · $1.40M · Q2 2026
- Northern Trust Corp 800.57K sh · $1.36M · Q2 2026
- Millennium Management 509.21K sh · $865.66K · Q2 2026
- Morgan Stanley 319.42K sh · $543.02K · Q2 2026